C4 Therapeutics Inc

Research C4 Therapeutics Inc (CCCC) on Bullrun: market cap USD 480.97M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerCCCC
• ExchangeNASDAQ
• CountryUnited States
• SectorHealthcare
• IndustryBiotechnology
• CurrencyUSD
• Market capUSD 480.97M
• Financial periodFY2025
• RevenueUSD 35.95M
• Revenue growth1.0%
• Net income-USD 104.99M
• Free cash flow-USD 99.30M

Valuation Snapshot

latest market cap is USD 480.97M.

About C4 Therapeutics Inc

C4 Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops novel therapeutic candidates to degrade disease-causing proteins. Its lead product candidate is Cemsidomide, an orally bioavailable monodac targeting IKZF1 and IKZF3, or IKZF1/3 to address a need across multiple lines of therapy in multiple myeloma, which has competed its phase 1.

Frequently asked questions

What is C4 Therapeutics Inc's market cap?

C4 Therapeutics Inc's market capitalization is USD 480.97M.

What does C4 Therapeutics Inc do?

C4 Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops novel therapeutic candidates to degrade disease-causing proteins.